Dornase alfa inhalation solution
| Dornase alfa inhalation solution | |
|---|---|
| Term | Dornase alfa inhalation solution |
| Short definition | Dornase alfa inhalation solution - (pronounced) (DOR-no AL-fuh in-huh-LAY-shun suh-LOO-shun) A drug given as an aerosol mist to reduce the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Dornase alfa inhalation solution - (pronounced) (DOR-no AL-fuh in-huh-LAY-shun suh-LOO-shun) A drug given as an aerosol mist to reduce the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. Dornase alfa inhalation solution contains an enzyme that breaks down the DNA in the mucus into small pieces and thins the mucus. Also called pulmozymes
External links
- Medical encyclopedia article on Dornase alfa inhalation solution
- Wikipedia's article - Dornase alfa inhalation solution
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski